Trade DOCMORRIS AG ORD - DOCM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.65 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.014959% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.007263% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 82.45 |
| Open | 83.4 |
| 1-Year Change | 120.93% |
| Day's Range | 82.3 - 84.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | 82.45 | -1.95 | -2.31% | 84.40 | 85.35 | 81.05 |
| Apr 24, 2024 | 85.90 | 2.00 | 2.38% | 83.90 | 87.85 | 83.50 |
| Apr 23, 2024 | 82.50 | 0.40 | 0.49% | 82.10 | 84.00 | 81.25 |
| Apr 22, 2024 | 81.10 | -0.90 | -1.10% | 82.00 | 83.30 | 79.40 |
| Apr 8, 2024 | 80.50 | 0.00 | 0.00% | 80.50 | 80.50 | 80.50 |
| Mar 28, 2024 | 80.50 | 0.00 | 0.00% | 80.50 | 80.50 | 80.50 |
| Mar 15, 2024 | 80.50 | 0.00 | 0.00% | 80.50 | 82.20 | 77.35 |
| Mar 14, 2024 | 79.85 | 5.80 | 7.83% | 74.05 | 80.90 | 70.10 |
| Mar 13, 2024 | 73.65 | -2.15 | -2.84% | 75.80 | 75.85 | 73.60 |
| Mar 12, 2024 | 73.95 | 0.05 | 0.07% | 73.90 | 75.45 | 72.05 |
| Mar 11, 2024 | 71.30 | 0.25 | 0.35% | 71.05 | 73.40 | 71.05 |
| Mar 8, 2024 | 71.35 | -1.80 | -2.46% | 73.15 | 73.20 | 69.00 |
| Mar 7, 2024 | 72.85 | 0.45 | 0.62% | 72.40 | 73.90 | 71.15 |
| Mar 6, 2024 | 72.55 | 2.05 | 2.91% | 70.50 | 76.45 | 70.50 |
| Mar 5, 2024 | 74.15 | -2.30 | -3.01% | 76.45 | 79.75 | 73.20 |
| Mar 4, 2024 | 74.80 | -3.40 | -4.35% | 78.20 | 78.20 | 74.30 |
| Mar 1, 2024 | 77.90 | -3.65 | -4.48% | 81.55 | 82.35 | 74.95 |
| Feb 29, 2024 | 81.20 | 0.05 | 0.06% | 81.15 | 83.20 | 77.90 |
| Feb 28, 2024 | 82.80 | -0.40 | -0.48% | 83.20 | 83.50 | 79.90 |
| Feb 27, 2024 | 84.00 | -0.35 | -0.41% | 84.35 | 85.35 | 82.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ZUR ROSE GROUP N Company profile
About Zur Rose Group AG
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zur Rose Group AG revenues increased 17% to SF1.73B. Net loss increased 66% to SF225.7M. Revenues reflect Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M, Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M. Higher net loss reflects Marketing and acquisition expenses increase of 96% to SF118.8M (expense).
Equity composition
11/2018 rights issue, adj. fct. 1.05607, new shares offered 2665476 (late adjustment from e-mail)
| Industry: | Drug Retailers (NEC) |
Walzmühlestrasse 49
FRAUENFELD
THURGAU 8500
CH
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com